Millipore Sigma Vibrant Logo

440202 LY 294002 - CAS 154447-36-6 - Calbiochem

LY294002, CAS 154447-36-6, is a cell-permeable, potent, reversible, and specific inhibitor of PI 3-kinase ((IC₅₀ = 1.4 µM). Acts on the ATP-binding site.

LY 294002 - CAS 154447-36-6 - Calbiochem: Ficha de dados de segurança do material (FDSM) ou ficha de segurança do material (FSM), certificado de análise (CA) e certificado de qualidade (CQ), dossiês e outros documentos disponíveis.

Sinônimos: 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, BRD2 Inhibitor IV, BRD3 Inhibitor III, BRD4 Inhibitor IV

Primary Target: Phosphatidylinositol 3-kinase
View Products on Sigmaaldrich.com
440202
Ver preços e disponibilidade

Panorama geral

Replacement Information

Tabela com principais espec.

CAS #Empirical Formula
154447-36-6C₁₉H₁₇NO₃

Preço e Disponibilidade

Número de catálogo DisponibilidadeEmbalagem Qtde/Emb. Preço Quantidade
440202-25MG
Verificando a disponibilidade...
—
Disponibilidade limitada Disponibilidade limitada
Insira quantidade 
Descontinuado
Quantidades limitadas disponíveis
Disponibilidade a ser confirmada
    Restante: será informado
      Restante: será informado
      Vai informar
      Contatar o serviço de atendimento ao cliente
      Contact Customer Service

      		 Ampola plástica 25 mg
      Recuperando preço...
      O preço não pôde ser recuperado
      Quantidade mínima necessária para ser múltipla de
      Maximum Quantity is
      Após finalização do pedido Mais informações
      Você salvou ()
       
      —
      Solicitar preço
      		 —
      440202-5MG
      Verificando a disponibilidade...
      —
      Disponibilidade limitada Disponibilidade limitada
      Insira quantidade 
      Descontinuado
      Quantidades limitadas disponíveis
      Disponibilidade a ser confirmada
        Restante: será informado
          Restante: será informado
          Vai informar
          Contatar o serviço de atendimento ao cliente
          Contact Customer Service

          		 Ampola plástica 5 mg
          Recuperando preço...
          O preço não pôde ser recuperado
          Quantidade mínima necessária para ser múltipla de
          Maximum Quantity is
          Após finalização do pedido Mais informações
          Você salvou ()
           
          —
          Solicitar preço
          		 —
          Description
          OverviewA cell-permeable, potent, reversible and specific phosphatidylinositol 3-kinase inhibitor (IC50 = 1.4 µM) that acts on the ATP-binding site of the enzyme. Also inhibits nonhomologous DNA end-joining (NHEJ) activity of the 460 kDa phosphatidylinositol 3-like kinase DNA-PKcs, which is the catalytic subunit of DNA-activated protein kinase. Does not affect the activities of EGF receptor kinase, MAP kinase, PKC, Pl 4-kinase, S6 kinase, and c-Src even at 50 µM. Promotes the nuclear accumulation of active GSK-3b. Reported to suppress the proliferation of murine embryonic stem cells. Blocks the proliferation of cultured rabbit aortic smooth muscle cells without inducing apoptosis. Shown to bind to the same site as I-BET (Cat. No. 40101050 ~ 10 µM). A 10 mM (1 mg/325 µl) solution of LY 294002 (Cat. No. 440204) in DMSO is also available.
          Catalogue Number440202
          Brand Family Calbiochem®
          Synonyms2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, BRD2 Inhibitor IV, BRD3 Inhibitor III, BRD4 Inhibitor IV
          References
          ReferencesDittman, A., et al. 2013. ACS Chem. Biol. 9, 495.
          Bechard, M., and Dalton. S. 2009. Mol. Cell. Biol. 29, 2092.
          Lianguzova, M.S. et al. 2007. Cell Biol. Int. 31, 330.
          Baumann, P., and West, S.C. 1998. Proc. Natl. Acad. Sci. USA 95, 14066.
          Cardone, M.H., et al. 1998. Science 282, 1318.
          Vlahos, C.J., et al. 1995. J. Immunol. 154, 2413.
          Yano, H., et al. 1995. Biochem. J. 312, 145.
          Vlahos, C.J., et al. 1994. J. Biol. Chem. 269, 5241.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.
          Product Information
          CAS number154447-36-6
          ATP CompetitiveY
          FormOff-white solid
          Hill FormulaC₁₉H₁₇NO₃
          Chemical formulaC₁₉H₁₇NO₃
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetPhosphatidylinositol 3-kinase
          Primary Target IC<sub>50</sub>1.4 µM against phosphatidylinositol 3-kinase
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de catálogo GTIN
          440202-25MG 04055977186673
          440202-5MG 07790788050290

          Documentation

          LY 294002 - CAS 154447-36-6 - Calbiochem MSDS

          Título

          Ficha de Segurança de Produtos (MSDS) 

          LY 294002 - CAS 154447-36-6 - Calbiochem Certificados de análise

          TítuloNúmero do lote
          440202

          Referências

          Visão geral de referência
          Dittman, A., et al. 2013. ACS Chem. Biol. 9, 495.
          Bechard, M., and Dalton. S. 2009. Mol. Cell. Biol. 29, 2092.
          Lianguzova, M.S. et al. 2007. Cell Biol. Int. 31, 330.
          Baumann, P., and West, S.C. 1998. Proc. Natl. Acad. Sci. USA 95, 14066.
          Cardone, M.H., et al. 1998. Science 282, 1318.
          Vlahos, C.J., et al. 1995. J. Immunol. 154, 2413.
          Yano, H., et al. 1995. Biochem. J. 312, 145.
          Vlahos, C.J., et al. 1994. J. Biol. Chem. 269, 5241.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.

          Brochura

          Título
          An Introduction to Inhibitors and Their Biological Applications - 1st Edition
          Bulk Product Guide

          Informações técnicas

          Título
          JAK/STAT Signaling Research Focus

          Ficha de dados

          Título
          Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

          Pôster

          Título
          Human Kinome & InhibitorSelect™ Libraries

          Citações

          Título
        • Bechard, M., and Dalton. S. 2009. Mol. Cell. Biol. 29, 2092.
        • Lianguzova, M.S. et al. 2007. Cell Biol. Int. 31, 330.
        • Oliveira, J.B., et al. 2007. Procedings of the National Academy of Science 104, 8953.
        • Satoshi Fukumoto, et al. (2006) Laminin 5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. Journal of Biological Chemistry 281, 5008-5016.
        • Ana Olivera, et al. (2006) IgE-dependent activation of sphingosine kinase 1 and 2 and secretion of sphingosine-1-phosphate requires Fyn kinase and contributes to mast cell responses. Journal of Biological Chemistry 281, 2515-2525.
        • Qian Yang, et al. (2006) TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proceedings of the National Academy of Sciences (USA) 103, 6811-6816.
        • Ying Zhang, Mingjuan Liao and Maria L. Dufau. (2006) Phosphatidylinositol 3-kinase/protein kinase Cγ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated depression of transcription of the luteinizing hormone receptor gene. Molecular and Cellular Biology 26, 6748-6761.
        • Huanyu Dou, et al. (2005) Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. Journal of Neuroscience 25, 8375-8385.
        • Julie Lotharius, et al. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed lineage kinase pathway. Journal of Neuroscience 25, 6329-6342.
        • Meenalakshmi M. Mariappan, M.M., et al. (2005) Phospholipase Cγ-Erk Axis in Vascular Endothelial Growth Factor-Induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells. Journal of Biological Chemistry 280, 28402-28411.
        • Michael Tscharntke, et al. (2005) Ras-induced spreading and wound closure in human epidermal keratinocytes. The FASEB Journal in press,.
        • Junji Tsurutani, et al. (2005) Inhibition of the phosphatidylinositol 3-kinase/Akt/Mammalian target of rapamycin pathway but no the MEK/ERK Pathway attentuates laminin-meidated small cell lunch cancer cellular survival and resistance to Imatinib mesylate or chemolyte.. Cancer Research 65, 8423-8432.
        • Xinbo Liao, et al. (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144, 1656-1663.
          		•
          Ficha de dados

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision28-February-2012 RFH
          Synonyms2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, BRD2 Inhibitor IV, BRD3 Inhibitor III, BRD4 Inhibitor IV
          DescriptionA cell-permeable, potent, reversible, and specific phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor that acts on the ATP-binding site of the enzyme (IC50 = 1.4 µM). Also inhibits nonhomologous DNA end-joining (NHED) in the 460 kDa phosphatidylinositol 3-like kinase DNA-PKcs, which is the catalytic subunit of DNA-activated protein kinase. Does not affect the activity of EGF receptor kinase, MAP kinase, PKC, PI 4-kinase, S6 kinase, and c-src at 50 µM. Promotes the nuclear accumulation of active GSK-3b. Reported to suppress the proliferation of murine embryonic stem cells. Blocks the proliferation of cultured rabbit aortic smooth muscle cells without inducing apoptosis. Reported to inhibit histamine secretion in RBL-2H3 cells (IC50 = 5 µM).
          FormOff-white solid
          CAS number154447-36-6
          Chemical formulaC₁₉H₁₇NO₃
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (20 mg/ml) or Ethanol. Slight warming may be required to achieve complete solubilization.
          Storage Protect from light
          -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesDittman, A., et al. 2013. ACS Chem. Biol. 9, 495.
          Bechard, M., and Dalton. S. 2009. Mol. Cell. Biol. 29, 2092.
          Lianguzova, M.S. et al. 2007. Cell Biol. Int. 31, 330.
          Baumann, P., and West, S.C. 1998. Proc. Natl. Acad. Sci. USA 95, 14066.
          Cardone, M.H., et al. 1998. Science 282, 1318.
          Vlahos, C.J., et al. 1995. J. Immunol. 154, 2413.
          Yano, H., et al. 1995. Biochem. J. 312, 145.
          Vlahos, C.J., et al. 1994. J. Biol. Chem. 269, 5241.



          Selected Citations
          Lee, J., et al. 2009. Cell Stem Cell 5, 76.
          Citation
        • Bechard, M., and Dalton. S. 2009. Mol. Cell. Biol. 29, 2092.
        • Lianguzova, M.S. et al. 2007. Cell Biol. Int. 31, 330.
        • Oliveira, J.B., et al. 2007. Procedings of the National Academy of Science 104, 8953.
        • Satoshi Fukumoto, et al. (2006) Laminin 5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. Journal of Biological Chemistry 281, 5008-5016.
        • Ana Olivera, et al. (2006) IgE-dependent activation of sphingosine kinase 1 and 2 and secretion of sphingosine-1-phosphate requires Fyn kinase and contributes to mast cell responses. Journal of Biological Chemistry 281, 2515-2525.
        • Qian Yang, et al. (2006) TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proceedings of the National Academy of Sciences (USA) 103, 6811-6816.
        • Ying Zhang, Mingjuan Liao and Maria L. Dufau. (2006) Phosphatidylinositol 3-kinase/protein kinase Cγ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated depression of transcription of the luteinizing hormone receptor gene. Molecular and Cellular Biology 26, 6748-6761.
        • Huanyu Dou, et al. (2005) Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. Journal of Neuroscience 25, 8375-8385.
        • Julie Lotharius, et al. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed lineage kinase pathway. Journal of Neuroscience 25, 6329-6342.
        • Meenalakshmi M. Mariappan, M.M., et al. (2005) Phospholipase Cγ-Erk Axis in Vascular Endothelial Growth Factor-Induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells. Journal of Biological Chemistry 280, 28402-28411.
        • Michael Tscharntke, et al. (2005) Ras-induced spreading and wound closure in human epidermal keratinocytes. The FASEB Journal in press,.
        • Junji Tsurutani, et al. (2005) Inhibition of the phosphatidylinositol 3-kinase/Akt/Mammalian target of rapamycin pathway but no the MEK/ERK Pathway attentuates laminin-meidated small cell lunch cancer cellular survival and resistance to Imatinib mesylate or chemolyte.. Cancer Research 65, 8423-8432.
        • Xinbo Liao, et al. (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144, 1656-1663.
          		•